CompoAtlas

AMMI VISNAGA

Food supplement declared in France, decision dated 1 November 2026

AMMI VISNAGA (PHYBIO) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition.

Brand
PHYBIO
Food business operator placing the product on the market
PHYBIO PHARMA SA
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Bottle
Daily dose
10 ml
Directions for use
50 gouttes trois fois par jour dans un verre d’eau. En cure de quinze jours par mois.
Intended populations
General population, Men and women aged 18 and over, Men, Women
Not recommended (according to the manufacturer)
Adolescents (under 18)
Objectives stated by the manufacturer (these are not authorised claims)
Menstrual cycles

Declaration 381125, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Ammi visnaga (L.) Lam.Parties aériennesTeinture10 ml

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Réservé à l'adulte. Déconseillé pendant la grossesse et l'allaitement. Demander l'avis d'un professionnel de santé en cas de traitement médicamenteux ou de pathologie. Par précaution, interrompre la prise avant toute intervention chirurgicale. Tenir hors de portée des jeunes enfants.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : PHYBIO

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line